Wall Street Zen Upgrades Hyperliquid Strategies (NASDAQ:PURR) to “Hold”

Hyperliquid Strategies (NASDAQ:PURR) was upgraded by Wall Street Zen to a “hold” rating in a report issued on Saturday.

A number of other equities analysts have also recently weighed in on PURR. Chardan Capital upped their price target on shares of Hyperliquid Strategies from $8.15 to $8.45 and gave the stock a “buy” rating in a research note on Thursday, February 12th. Cantor Fitzgerald upped their target price on shares of Hyperliquid Strategies from $5.00 to $6.00 and gave the stock an “overweight” rating in a research report on Thursday, February 12th. Two investment analysts have rated the stock with a Buy rating, Based on data from MarketBeat, Hyperliquid Strategies presently has an average rating of “Buy” and a consensus price target of $7.23.

Hyperliquid Strategies Trading Up 6.7%

NASDAQ PURR opened at $4.29 on Friday. Hyperliquid Strategies has a 12-month low of $3.01 and a 12-month high of $5.78.

Hyperliquid Strategies (NASDAQ:PURR) last posted its quarterly earnings results on Wednesday, February 11th. The company reported ($7.43) EPS for the quarter. The firm had revenue of $0.50 million during the quarter.

Institutional Investors Weigh In On Hyperliquid Strategies

Institutional investors and hedge funds have recently made changes to their positions in the business. Paradigm Operations LP acquired a new stake in Hyperliquid Strategies in the 4th quarter valued at about $20,327,000. Galaxy Group Investments LLC acquired a new stake in shares of Hyperliquid Strategies in the fourth quarter valued at approximately $15,167,000. Pantera Capital Partners LP purchased a new position in shares of Hyperliquid Strategies during the 4th quarter worth approximately $14,545,000. Feynman Point Asset Management LLC acquired a new position in shares of Hyperliquid Strategies during the 4th quarter worth approximately $14,431,000. Finally, 683 Capital Management LLC acquired a new position in shares of Hyperliquid Strategies during the 4th quarter worth approximately $5,660,000. 9.45% of the stock is currently owned by hedge funds and other institutional investors.

Hyperliquid Strategies Company Profile

Hyperliquid Strategies Inc is a digital asset treasury company whose primary focus is to maximize shareholder value through accumulating HYPE, the native token of Hyperliquid, a high-performance blockchain custom-built to house all of finance. Hyperliquid Strategies Inc, formerly known as Sonnet BioTherapeutics Holdings Inc, is based in NEW YORK.